Impact Medicine Fund Lp Sv7 serves as Executive at Xilio Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Impact Medicine Fund Lp Sv7 has executed 6 insider transactions totaling $10.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 26, 2021 involved purchasing 312,500 shares valued at $5.0M.
Impact Medicine Fund Lp Sv7 currently holds 1,613,632 shares of Xilio Therapeutics, Inc. (XLO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Impact Medicine Fund Lp Sv7 has been a net buyer of XLO stock. They have purchased $10.0M and sold $0 worth of shares.
Impact Medicine Fund Lp Sv7's most recent insider trade was on Oct 26, 2021, when they purchased 312,500 shares at $16.00 per share.
Get notified when new Form 4 filings are submitted
| $16.00 |
| Discretionary |
| Oct 26, 2021 | XLO | $0 | Conversion | 302,588 | $N/A | Discretionary |
| Oct 26, 2021 | XLO | $0 | Conversion | 302,588 | $N/A | Discretionary |
| Oct 26, 2021 | XLO | $0 | Conversion | 998,544 | $N/A | Discretionary |
| Oct 26, 2021 | XLO | $0 | Conversion | 998,544 | $N/A | Discretionary |